SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-14-030694
Filing Date
2014-04-25
Accepted
2014-04-25 16:41:02
Documents
2
Period of Report
2014-02-18
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a14-11150_18ka.htm 8-K/A 25326
2 EX-2.1 a14-11150_1ex2d1.htm EX-2.1 660162
  Complete submission text file 0001104659-14-030694.txt   686655
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35119 | Film No.: 14786089
SIC: 2834 Pharmaceutical Preparations